Guardian Pharmacy Services (GRDN) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.29
- Estimate
- $0.27
- Surprise
- +5.8%
- Revenue (period 2026-06-30)
- $351.8M
- Score today
- 5.9/10
Revenue source: xbrl.
How the report landed
Guardian Pharmacy Services (GRDN) beat the $0.27 estimate with diluted EPS of $0.29 — a clear 5.8% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates GRDN Hold at 5.9/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +5.8% surprise compares with a +17.8% four-quarter average. Next scheduled report: 2026-11-09.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Customer: ALF and BHF residents
- Analyst target reached - limited upside remaining
- Overbought (RSI 85)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $43.64
- Price target
- $50.19
- Stop
- $40.66
- Upside to target
- +15.0%
The stock trades at 42.0× trailing but 30.5× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 85 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 2.1× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.
GRDN at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $2.76B
- P/E (fwd)
- 30.5
- P/E (ttm)
- 42.0
- 52-week range
- $23.14–$47.02
- Off 52-week high
- 7.2%
- RSI (14)
- 85
- Volume vs avg
- 2.12×
- Score today
- 5.9/10